Results 1 to 10 of about 40,657 (187)
Predicting the blood concentration of levetiracetam in people with epilepsy using machine learning and real-world data [PDF]
Therapeutic Advances in PsychopharmacologyBackground: Levetiracetam is an antiepileptic drug widely used to treat partial and generalized seizures in clinicians. The effectiveness and safety of levetiracetam in individuals with epilepsy are affected by various complex factors, including ...
Bolin Zhu +3 more
doaj +2 more sources
Efficacy of Levetiracetam Use in Neonatal Seizure: A Retrospective Cohort Study [PDF]
NeuroSciNeonatal seizures are common complications in neonatal intensive care units. They have been noticed to be more common in preterm infants, but they can also affect term infants. Levetiracetam is a broad-spectrum antiepileptic drug that has been studied to
Faisal Aqeel Alsehli +12 more
doaj +2 more sources
Journal of Pain and Symptom Management, 2018 Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com).
Paul, Howard +8 more
+8 more sources
Levetiracetam Therapeutic Drug Monitoring in a Large Cohort of Korean Epileptic Patients
Pharmaceuticals, 2021 Levetiracetam is a new antiepileptic drug (AED) used for treating and preventing partial or generalized seizures. The usefulness of levetiracetam therapeutic drug monitoring (TDM) is related to inter- or intra-individual pharmacokinetic variability, drug
Changhee Ha +6 more
doaj +1 more source
Levetiracetam-Induced Pancytopenia in an HIV Seropositive Patient With SARS-CoV-2
Annals of Internal Medicine: Clinical Cases, 2022 Levetiracetam is a widely used and safe antiepileptic drug, and levetiracetam-induced pancytopenia is an uncommon adverse effect. We present a patient case of a middle-aged man with seizures who developed profound pancytopenia within 4 days of starting ...
Lemchukwu Chukwunonye Amaeshi +4 more
doaj +1 more source
Neurodevelopmental outcomes in children exposed prenatally to levetiracetam
Therapeutic Advances in Drug Safety, 2022 Some old antiseizure medications (ASMs) pose teratogenic risks, including major congenital malformations and neurodevelopmental delay. Therefore, the use of new ASMs in pregnancy is increasing, particularly lamotrigine and levetiracetam.
Bshra A. Alsfouk
doaj +1 more source
Journal of Health Science and Medical Research (JHSMR), 2021 Objective: Levetiracetam is commonly used in malignant glioma populations because of its efficacy, limited drug-drug interactions and adverse effects. Although, there has been growing evidence of adverse neuropsychiatric side effects from levetiracetam ...
Paul Thisayakorn, Isabel Schuermeyer
doaj +1 more source
Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
Palliative Medicine Reports, 2021 We report on a patient suffering from seizures caused by cerebral metastases of adenocarcinoma of the lung. Initially, the patient was treated effectively with oral levetiracetam. As the disease progressed, oral intake was no longer possible.
Sophia Westphal +3 more
doaj +1 more source
Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
Respiratory Medicine Case Reports, 2020 An 85-year-old woman with antibiotics-resistant pneumonia after surgery for metastatic brain tumor from lung cancer was consulted to our department. Chest CT showed diffuse GGO bilaterally. BALF showed elevated ratios of lymphocytes and CD4/CD8.
Shintaro Sato +12 more
doaj +1 more source
A case of rhabdomyolysis in which levetiracetam was suspected as the cause
Epilepsy and Behavior Case Reports, 2014 Several studies have reported rhabdomyolysis induced by various drugs but not by the antiepileptic drug levetiracetam. We present a case of suspected levetiracetam-induced rhabdomyolysis.
Hisanao Akiyama +4 more
doaj +1 more source